F.D.A. Approves New Obesity Drug That Will Compete With Wegovy

Health
By Gina Kolata from NYT Health https://ift.tt/OTpngq6
via IFTTT your-feed-science, Drugs (Pharmaceuticals), Semaglutide (Drug), Obesity, Weight Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

Comments

Post a Comment

Popular posts from this blog

Should the Autism Spectrum Be Split Apart?

Image
Health By Azeen Ghorayshi from NYT Health https://ift.tt/ZX2NkH3 via IFTTT Autism, Intellectual Disabilities, Asperger's Syndrome, Special Education, Mental Health and Disorders, Children and Childhood, United States Politics and Government, Medicine and Health Families of people with severe autism say the repeated expansion of the diagnosis pushed them to the sidelines. A new focus on the disorder has opened the way for them to argue their cause.
Read more

The Young Women Grappling With an ‘Old Man’s Disease’

Image
Health By Roni Caryn Rabin and Lucy Lu from NYT Health https://ift.tt/rBAEXmJ via IFTTT your-feed-science, Amyotrophic Lateral Sclerosis, Women and Girls, Age, Chronological, Parties (Social), audio-positive-happy, audio-negative-sad, Disabilities, Travel and Vacations, Content Type: Personal Profile Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod.
Read more